Our client was approaching the launch of a new product for treatment of a mental health disorder. Despite promising trial data, successful adoption of their therapy would be challenging for a number of reasons. Read the case study.

Medical Affairs

Pioneering Treatment Paradigm in Neurology

Discover how we assisted our client in positioning their therapy for optimal impact in the evolving landscape of steroid reduction and global treatment strategies.

Medical Affairs

Strategic Repositioning of a GI Market Leader Amidst Evolving Market Dynamics

Explore how we analyzed and refined our client's drug positioning across multiple indications to ensure market alignment and strategic coherence. Read the case study.

Medical Affairs

Communication Strategy for Novel MOA in Neurological Disorder

Our client aimed to apply a proven molecule to a new neurological disorder. We helped create a compelling narrative and cost-effective strategy to boost ROI. Read the case study.

Medical Affairs

Establishing the Scientific Stories of Novel Gene Therapies

Learn how we guided our client through early-stage clinical trials and competitive pressures to craft a compelling scientific narrative. Read the case study.

Medical Affairs

Strategic Launch in a Rare Hematologic Disease

Learn how we navigated the challenges of launching a novel treatment in a rare hematologic disease to position our client's drug as a potential new standard of care. Read the full case study.

Market Access

Value-Based Contracting Strategy and Playbook

We helped our major pharmaceutical client equip it organization to offer value-based contracts to support access for a new specialty drug. Read the case study.

Market Access

Reimbursement Strategy for Ophthalmic Insert

Discover how our tailored reimbursement strategy propelled a small biotech's innovative ophthalmic product to exceed launch forecasts by 60% in patient treatment.

Market Access

Communicating Value to Payers for New Auto-Immune Product

We helped a biopharma company design a compelling payer value story presentation for its new auto-immune product

Market Access

Economic Model Quantifying Rx to OTC Availability

We partnered with our client to establish a narrative that increased availability results in improvements in health outcomes and downstream cost savings. Read the case study.

Market Access

Evidence Generation Strategy – Cystic Fibrosis Asset/COPD

We helped a client’s new product team plan their US and EU access strategies for a novel compound with potential in both rare and more common respiratory conditions. Read the case study.

Medical Affairs

Enhancing Manuscripts for Top-Tier Journal Publication

We helped a clinical-stage genetic medicine company enhance their manuscript and figures to meet the high standards of a top scientific journal. Discover how our targeted narrative refinement and figure enhancement led to their research being featured in a prestigious journal with an impact factor of 4.6.

Insights and Analytics

Competitor Analysis for Gene Therapy

A prominent pharmaceutical company launching its first to market gene therapy in a rare disease was seeking to enhance its market position and reimbursement approach.

Launch Excellence

Co-commercialization Case Study for a First Oncology Launch

A mid-sized global pharmaceutical organization entered a co-commercialization agreement with a top-10 pharmaceutical organization to launch its first product in oncology.

Patient Services

Patient Services Launch Diagnostic

Support programs have the power to drive patients to start, stay and succeed on therapy. These programs and the best practices that drive patient experience and access are critical to success.

Market Access

Evidence Generation Strategy for a New Drug Formulation

A global pharmaceutical company worked with us to plan their European Union (EU) access strategy for a novel oncolytic drug based on a new formulation. Read the case study.

Market Access

Payer Value Proposition Development in a Crowded Disease Space

Our client, a mid-sized biopharmaceutical company, aimed to introduce a new asset into the highly competitive Parkinson's disease category. Read the case study.

Medical Affairs

Development of a Scientific Platform for Biotech Client

Our biotech client was facing the challenge of introducing a new competitor into the market while simultaneously gaining a deeper understanding of their disease state. To navigate this complex scenario, they needed a strategic document that would serve as the foundation for both internal and external communications.

Medical Affairs

KOL Identification and Engagement Planning in Rare Disease Clinical Development

Our client, a leading biopharmaceutical company, sought to embark on a clinical development program within a new therapeutic area in the rare disease space. Read the case study.

Launch Excellence

Oncology Product Launch Plan and Execution for Rare Disease Indication

Leading biotech engaged Herspiegel for critical oncology drug launch in a competitive market, showcasing a dedicated, innovative approach.

Successful Launch of Phase 3 Asset in Different Therapeutic Areas

Dual-launch success in two areas! Herspiegel expertly guides Phase 3 asset to market. Discover our strategy's impact.

Patient Journey and Product Launch Planning – Oncology

Explore Herspiegel's approach to Oncology Patient Journey Mapping for new cancer therapy launches. Learn about our innovative strategies.

Early Commercialization for Oncology Start-Up

Join our journey in guiding an oncology start-up towards successful first product launch with expert strategies. Discover our impact.

Redesigning a Patient Support Program to Successfully Deliver Treatments to Patients with Complex Conditions

Learn how Herspiegel's redesigned patient HUB enhances treatment access for complex conditions. Dive into our case study now.

Product Development Process to Optimize Commercial Value

Maximize your biopharma product's commercial success! Discover how Herspiegel's refined development process can drive market results. Learn more now

First Connected Device Launch Plan

Explore how Herspiegel's expertise led a groundbreaking connected device launch in healthcare. Dive into our digital and business insights.

First Commercial Launch for Biopharmaceutical Start-Up

Discover how Herspiegel's guidance powered a biopharma start-up's first Neurology asset launch, crafting their commercial triumph. Learn more.

Case Studies

Redefining the Treatment Paradigm in Mental Health